← Back to Search

Treatment for Alzheimer's Disease (LIFE-DSR Trial)

N/A
Waitlist Available
Research Sponsored by LuMind IDSC Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 2 years
Awards & highlights

Summary

The primary objective is to characterize trajectories of change on the primary outcome measures in this study population through longitudinal collection of measures of cognition, function, behavior, and health status.

Eligible Conditions
  • Alzheimer's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Behavioral Measure
Cognitive Measure
Functional Measure
+1 more
Secondary outcome measures
Exploratory Outcome Measure Novel multi-domain instrument for AD-DS development
Exploratory Outcome Measure Potential Screening Measures
Exploratory Outcome Measure Preliminary composite measure from the scales being used in LIFE-DSR

Find a Location

Who is running the clinical trial?

LuMind IDSC FoundationLead Sponsor
3 Previous Clinical Trials
92 Total Patients Enrolled
Alzheimer's Disease Cooperative Study (ADCS)OTHER
24 Previous Clinical Trials
6,179 Total Patients Enrolled
Lois KellyStudy DirectorLuMind IDSC Foundation
~41 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top